| ￥1200 | |
| A04056 | |
|
|
|
|
|
|
|
|
|
| Specificity | This product is specific to FATP 4 |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human FATP 4 |
| Species Reactivity | Human; Mouse; Rat |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||
|
|||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
| Target Background | Mediates the levels of long-chain fatty acids (LCFA) in the cell by facilitating their transport across cell membranes.Appears to be the principal fatty acid transporter in small intestinal enterocytes.Also functions as an acyl-CoA ligase catalyzing the ATP-dependent formation of fatty acyl-CoA using LCFA and very-long-chain fatty acids (VLCFA) as substrates, which prevents fatty acid efflux from cells and might drive more fatty acid uptake. |
| Synonyms | ACSVL4; FATP4; Fatty acid transport protein 4; IPS; S27A4; Solute carrier family 27 member4; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
